GnRH agonists
Frozen thawed embryo transfer cycles; A comparison of pregnancy outcomes with and without prior pituitary suppression by GnRH agonists: An RCT
8
GnRH agonists induce endometrial epithelial cell apoptosis via GRP78 down regulation
10
GnRH Agonists: Are They Ready for Clinical Use as an Anti-adhesive Agent? A Review of the Literature
10
<p>Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis</p>
9
GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
6
GnRH analogs for the treatment of symptomatic uterine leiomyomas
7
Strategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders
7
ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
7
Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis
16
PubMedCentral-PMC4960458.pdf
16
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
10
Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis
11
GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?
7
Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
9
Gonadotropin releasing hormone receptor mRNA expression by human pituitary tumors in vitro
9
Decreased FGF8 signaling causes deficiency of gonadotropin releasing hormone in humans and mice
11
Effects of decreasing the frequency of gonadotropin releasing hormone stimulation on gonadotropin secretion in gonadotropin releasing hormone deficient men and perifused rat pituitary cells
10
GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial
8
Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis
11
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
8